(NURE) Nuveen Short-Term REIT - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US67092P7069 • Real Estate

NURE: Real Estate, Investment Trusts, US Equities

The Nuveen Short-Term REIT ETF (BATS:NURE) is designed to provide exposure to the U.S. real estate sector through a concentrated portfolio of Real Estate Investment Trusts (REITs). The fund adheres to an 80% investment policy, meaning it allocates at least 80% of the sum of its net assets and any borrowings for investment purposes to REITs. This approach ensures a focused exposure to the real estate market, targeting equity REITs that generate most of their revenue from property ownership and operations. The fund is non-diversified, allowing it to take larger positions in select securities, which can lead to higher volatility but also potentially higher returns.

The ETF tracks a subset of the Dow Jones U.S. Select REIT Index, which includes equity REITs listed on U.S. national securities exchanges. To qualify for inclusion, these REITs must derive at least 75% of their total revenue from real estate assets and have a minimum market capitalization of $200 million at the time of inclusion. This methodology ensures that the fund focuses on established, revenue-generating real estate companies. The funds structure allows investors to gain access to the U.S. real estate market through a single, liquid traded instrument. Additional information about the fund can be found at the Nuveen website: http://www.nuveen.com.

From a technical perspective, NURE is currently trading at $32.39, slightly above its 20-day moving average of $31.86 and 50-day moving average of $31.54, but near its 200-day moving average of $31.88. This suggests the fund is in a period of consolidation. The Average True Range (ATR) of 0.41 indicates moderate volatility, while the average 20-day volume of 9,856 shares reflects moderate trading activity. The funds assets under management (AUM) of $51.93 million suggest a smaller but still viable ETF in the real estate category.

3-Month Forecast: Based on the provided and , NURE is expected to trade in a range-bound manner over the next three months, with potential support near its 200-day moving average of $31.88 and resistance around $33.00. The moderate ATR of 0.41 suggests that price fluctuations will likely remain contained, with average daily moves of less than 1.3%. The funds AUM of $51.93 million indicates a smaller ETF, which may experience slightly higher sensitivity to market movements compared to larger funds in the real estate category. Overall, NURE is positioned to reflect broader trends in the U.S. REIT market, with a focus on equity REITs that generate significant revenue from real estate operations.

Additional Sources for NURE ETF

NURE ETF Overview

Market Cap in USD 52m
Category Real Estate
TER 0.35%
IPO / Inception 2016-12-19

NURE ETF Ratings

Growth 5y 39.5%
Fundamental -
Dividend 61.6%
Rel. Strength Industry -1.44
Analysts -
Fair Price Momentum 30.35 USD
Fair Price DCF -

NURE Dividends

Dividend Yield 12m 3.51%
Yield on Cost 5y 4.83%
Annual Growth 5y 7.54%
Payout Consistency 82.5%

NURE Growth Ratios

Growth Correlation 3m -12.9%
Growth Correlation 12m 65.8%
Growth Correlation 5y 42.5%
CAGR 5y 6.90%
CAGR/Max DD 5y 0.18
Sharpe Ratio 12m 1.28
Alpha -0.50
Beta 0.60
Volatility 17.29%
Current Volume 2.2k
Average Volume 20d 8k
What is the price of NURE stocks?
As of March 09, 2025, the stock is trading at USD 32.23 with a total of 2,191 shares traded.
Over the past week, the price has changed by -0.63%, over one month by +1.48%, over three months by -3.98% and over the past year by +9.15%.
Is Nuveen Short-Term REIT a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Nuveen Short-Term REIT (BATS:NURE) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 39.52 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NURE as of March 2025 is 30.35. This means that NURE is currently overvalued and has a potential downside of -5.83%.
Is NURE a buy, sell or hold?
Nuveen Short-Term REIT has no consensus analysts rating.
What are the forecast for NURE stock price target?
According to ValueRays Forecast Model, NURE Nuveen Short-Term REIT will be worth about 34.3 in March 2026. The stock is currently trading at 32.23. This means that the stock has a potential upside of +6.27%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 34.3 6.3%